Showing results (331-340 of 351) with videos related to
Sort By:
Pageof 36
Leukemia|December 22, 1999
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemiaJ J van Dongen, E A Macintyre, J A Gabert, et al.Leukemia|December 28, 2016
PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemiasC Ronchini, A Brozzi, L Riva, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective studyM T Voso, G Leone, A Piciocchi, et al.Bone Marrow Transplantation|June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMTS P Robinson, C Canals, J J Luang, et al.Bone Marrow Transplantation|January 10, 2017
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)E Todisco, F Ciceri, C Boschini, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 21, 2018
The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trialA K Nordklint, T P Almdal, P Vestergaard, et al.Journal of Internal Medicine|December 8, 2017
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemiaC Craddock, J Versluis, M Labopin, et al.Leukemia|March 2, 2012
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patientsA Rambaldi, A Bacigalupo, R Fanin, et al.Leukemia|February 19, 2013
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinibF Efficace, M Baccarani, M Breccia, et al.ESMO Open|August 5, 2021
Skip pattern approach toward the early access of innovative anticancer drugsG Apolone, A Ardizzoni, A Biondi, et al.Pageof 36